Digest Network Come funziona
Network
/
Società
TR
Non verificato

TRIANA Biomedicines, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

5 comunicati stampa

Guarda tutti i comunicati
09/09/2026
Eventi
Industria
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Oncologia
TRIANA Biomedicines Announces Publication of Preclinical Data Supporting Clinical Advancement of TRI-611
Fonte
TRIANA Biomedicines, Inc.
Emittente
Business Wire
1.00
0
18/05/2026
Mercato del lavoro
Biotecnologia
Farmaceutica
Salute
Oncologia
TRIANA Biomedicines Announces the Appointment of Mohan Bala as Chief Operating Officer and Attracts Leading Experts to its Scientific Advisory Board
Fonte
TRIANA Biomedicines, Inc.
Emittente
Business Wire
1.00
0
25/03/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
TRIANA Biomedicines’ TRI-611 Granted U.S. FDA Fast Track Designation for Treatment of ALK Positive Non-small Cell Lung Cancer
Fonte
TRIANA Biomedicines, Inc.
Emittente
Business Wire
1.00
0
19/03/2026
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
TRIANA Biomedicines Announces First Patient Dosed in a Phase 1/2 Trial Evaluating TRI-611 for the Treatment of ALK Positive Non-small Cell Lung Cancer
Fonte
TRIANA Biomedicines, Inc.
Emittente
Business Wire
1.00
0
03/12/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
TRIANA Biomedicines Announces Oversubscribed $120M Series B Financing to Advance its Molecular Glue Degrader Pipeline
Fonte
TRIANA Biomedicines, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0